Skip to main content

UBS Group AG

Position in BFRI — Biofrontera Inc.

CIK 1610520 ZURICH, V8

Position in BFRI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,517
+$16,272 QoQ
Shares Held
18,860
+901.6% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 19 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BFRI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,073 across 82 Drug Manufacturers - Specialty & Generic names. BFRI ranks #62 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BFRI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 BFRIW 342
2026-06-30 $17,517 18,518
2026-03-31 BFRIW 343
2026-03-31 $1,245 1,540
2025-12-31 BFRIW 343
2025-12-31 $5,907 10,365
2025-09-30 $973 988
2025-06-30 $712 1,001
2025-03-31 BFRIW 891
2025-03-31 $24 31
2024-12-31 BFRIW 2,519
2024-12-31 $15,338 14,073
2024-09-30 BFRIW 6,324
2024-09-30 $4,121 3,099
2024-06-30 BFRIW 10
2024-06-30 $8,995 10,017
2024-03-31 BFRIW 2,604
2023-12-31 BFRIW 210
2023-09-30 BFRIW 69
2023-09-30 $8 1
2023-03-31 $739 1,212
2022-12-31 BFRIW 10
2022-09-30 BFRIW 4,283
2022-09-30 $4,977 4,740
2022-06-30 BFRIW 3,853
2021-12-31 BFRIW 2,750